v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net Sales $ 1,607,883 $ 895,655
Cost of Goods Sold 218,366 139,475
Gross Profit 1,389,517 756,180
Selling Expenses 824,336 500,119
Research and Development 99,567 117,867
General and Administrative 2,206,293 2,433,292
Operating Loss (1,740,679) (2,295,098)
Other Income (Expense):    
Interest expense (26,189) (2,237)
Change in fair value of warrant liability (31,506) 1,831
Other income 36,942 16,820
Total other (expense) income, net (20,753) 16,414
Net Loss (1,761,432) (2,278,684)
Preferred stock dividends (189,399) (213,543)
Net Loss Available to Common Stockholders $ (1,950,831) $ (2,492,227)
Per-Share Data    
Basic loss per share $ (0.18) $ (0.33)
Diluted loss per share $ (0.18) $ (0.33)
Weighted Average Common Shares Outstanding    
Basic 10,948,121 7,463,578
Diluted 10,948,121 7,463,578